Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Trabedersen by Sapu Bioscience for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Trabedersen is under clinical development by Sapu Bioscience and currently in Phase III for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Trabedersen by Sapu Bioscience for Solid Tumor: Likelihood of Approval
Trabedersen is under clinical development by Sapu Bioscience and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Trabedersen by Oncotelic Therapeutics for Metastatic Pancreatic Cancer: Likelihood of Approval
Trabedersen is under clinical development by Oncotelic Therapeutics and currently in Phase III for Metastatic Pancreatic Cancer. According to GlobalData,...